InsidersTradesSigma
Hansoh Pharmaceutical Group Co. Ltd.: directors' dealings · Hong Kong · HKEX
HKEX:hansoh-pharmaceutical-group-co-ltdHK·HKEXMcap 207.1Bn€Healthcare
Explore the full insider trade history of Hansoh Pharmaceutical Group Co. Ltd., a listed equity based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, Hansoh Pharmaceutical Group Co. Ltd. has recorded 6 insider filings. Market capitalisation: €207.1bn. The latest transaction was reported on 4 May 2026 — Other. Among the most active insiders: Lyu Aifeng. Every trade is free.
6
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
€3m
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
34.16 €
Analyst consensus
22 analysts38.59 €Target 46.65 €(+37%)52.56 €
Income statement
Revenue15.03 Bn€
Gross profit13.53 Bn€90% margin
Net income5.56 Bn€37.0% margin
Valuation
PER (trailing)31.9x
PER (forward)31.4x
P/Book5.1x
Beta0.55
Balance sheet & cash
Market cap207.11 Bn€
Total debt105.1 M€
Free Cash Flow6.25 Bn€
Debt / Equity0%
Profitability & ownership
ROE17.3%
ROA9.4%
% insiders79.5%
% institutions15.9%
Last declaration on 4 May 2026
Declarations6 total
Executives●Other8HKEX
€32,37664,845 shares@ €0.49930.0000% mcap2.3% of flow
ShareXHKG
HKEX:DA20260430E00535·
Executives●Purchase8HKEX
109,010 shares
ShareXHKG
HKEX:DA20260430E00527·
Ideal exit: 23 Jan 2027 (T+270)
Executives●Other8HKEX
€55,256178,200 shares@ €0.31010.0000% mcap4.0% of flow
ShareXHKG
HKEX:DA20260430E00533·
Executives●Sale16HKEX
€1m300,000 shares@ €4.30160.0006% mcap93.6% of flow
ShareXHKG
HKEX:DA20260423E00042·
6 of 6 declarations